Andrx Q2 swings to profit

GregMorcroft

NEW YORK (CBS.MW) -- Drug maker Andrx
adrx
said a new pair of its genetic drugs launched in the second quarter helped lift the company to its second straight quarterly profit. The company posted second quarter net income of $14.5 million, or 20 cents per share, compared to a loss of $29.8 million, or 42 cents per share a year ago. The company posted second quarter revenue of $272.4 million versus $180.5 million a year ago. The latest quarterly results beat the average analyst estimate of 19 cents per share, as compiled by Reuters Research.

Intraday Data provided by SIX Financial Information and subject to terms of use.
Historical and current end-of-day data provided by SIX Financial Information.
All quotes are in local exchange time. Real-time last sale data for U.S. stock quotes reflect trades reported through Nasdaq only.
Intraday data delayed at least 15 minutes or per exchange requirements.